Zafgen Joins NORD in Raising Awareness of Rare Disease Day
Feb 29, 2016 12:00 pm UTC| Business
BOSTON, Feb. 29, 2016 -- Zafgen Inc., a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today announced its...
Feb 29, 2016 12:00 pm UTC| Business
PARIS, Feb. 29, 2016 -- GenSight Biologics S.A. (GenSight), a clinical-stage biotechnology company discovering and developing novel gene therapies for neurodegenerative retinal diseases, and in the future, of the...
Curis Reports Fourth Quarter and Year-End 2015 Financial Results
Feb 29, 2016 12:00 pm UTC| Business
LEXINGTON, Mass., Feb. 29, 2016 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today reported its...
Feb 29, 2016 12:00 pm UTC| Business
WARREN, N.J., Feb. 29, 2016 -- ANADIGICS, Inc. (Nasdaq:ANAD) (“ANADIGICS” or the “Company”) today announced that it received from II-VI Incorporated (“II-VI”) on February 26, 2016 a further revised set of proposed...
Plug Power VP to Present at 28th Annual ROTH Conference
Feb 29, 2016 12:00 pm UTC| Business
LATHAM, N.Y., Feb. 29, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing clean, reliable energy solutions, is pleased to announce that Vice President of Business Development and Investor Relations, John...
Feb 29, 2016 12:00 pm UTC| Business
NS2 Demonstrates Statistically Significant and Sustained Clinical Effects Data Suggest Aldehyde Trapping as Novel Approach for the Treatment of Inflammatory DiseasesConference Call to Be Held Today at 8:00 am ETLEXINGTON,...
Feb 29, 2016 12:00 pm UTC| Business
Adjusted EBITDA, a non-GAAP measure, was $26.5 million(1) for the 4th quarter 2015, an increase of over 15% compared with the prior year 4th quarter. Calendar year 2015 Adjusted EBITDA was $98.2 million, an increase of...